Chromosome
3 minutes ago
Sleven, to add to that I think ANRN is an unborn among biotechs. The reason biotechs fail is because the science fails. If n that case nothing will fix the failure. In AMRN’s case, it’s a business execution and market development issue. If these two components fail, the asset is still valuable and s